S. Wayne Mascarella
13Patents
5h-index
13Co-inventors
59Inventor score
Filing activity: Mar 9, 1999 → Sep 15, 2017
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6559159B2 | Kappa opioid receptor ligands | Human Necessities | 106 | Expired |
| US6593348B2 | Opiate compounds, methods of making and methods of use | Chemistry; Metallurgy | 43 | Expired |
| US6531481B2 | Opiate compounds, methods of making and methods of use | Chemistry; Metallurgy | 17 | Expired |
| US6900228B1 | Opiate compounds, methods of making and methods of use | Chemistry; Metallurgy | 16 | Expired |
| US6552032B2 | Opiate compounds, methods of making and methods of use | Chemistry; Metallurgy | 14 | Expired |
| US8906908B2 | Hydroxybupropion analogues for treating drug dependence | Human Necessities | 4 | Active |
| US7476679B2 | Octahydroisoquinoline compounds as opioid receptor modulators | Chemistry; Metallurgy | 4 | Active |
| US6974824B2 | Kappa opioid receptor ligands | Human Necessities | 4 | Expired |
| US9273027B2 | Arylpiperazine opioid receptor antagonists | Chemistry; Metallurgy | 1 | Active |
| US11292783B2 | Substituted 1,2,3,4-tetrahydroisoquinolines as kappa opioid antagonists | Chemistry; Metallurgy | 0 | Active |
| US9512105B2 | 1-substituted 4-arylpiperazine as kappa opioid receptor antagonists | Chemistry; Metallurgy | 0 | Active |
| US9750738B2 | Arylpiperazine opioid receptor antagonists | Chemistry; Metallurgy | 0 | Active |
| US9527823B2 | Hydroxybupropion analogues for treating drug dependence | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.